Company News & Press

Media, Press, and other Proxima Company Updates

SXSW 2022: Houston House Spotlights Tech and Innovation at SXSW

Proxima Clinical Research Selected as One of The Fastest Growing Private Companies in the Southwest Region by Inc. Magazine.

Newsletter: Curing Mouse Cancer + J&J’s Secret Asbestos Trial | March 15th, 2022

Newsletter: MedTech Marvels & A New HIV Cure | February 28th, 2022

Kevin Coker: Medical Device Trends to Watch for in 2022 and Beyond

Proxima Clinical Research Guides EvoEndo to Successful 510(k) for Safer and More Cost-Effective Upper Endoscopic Procedures for Patients, Doctors, and Hospitals

Kevin Coker: 10 Innovation Tips Big Businesses Can Learn From Small Businesses

Newsletter: We <3 Innovators | February 14th, 2022

Update: Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients

Kevin Coker: Inspired By Another Company’s Product? How To Succeed With A Copycat

Newsletter: Cyber Drugs & The Biotech Bear | February 1st, 2022

Kevin Coker: Want To Generate More Leads? Try These Expert-Recommended Strategies

Proxima Newsletter

Rants, raves and observations.
Occasionally an opinion or fact.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Expertise

Resources

Company

Company Updates

Connect

2450 Holcombe Blvd.
Houston, TX 77021

Hello@ProximaCRO.com
+1.936.463.2221‬

Proxima Clinical Research, Inc. (aka Proxima CRO) is a registered Delaware C Corp, headquartered in Houston, TX
© Copyright 2024 Proxima Clinical Research, Inc. All Rights Reserved.